Cargando…
A Pilot Longitudinal Study on Cerebrospinal Fluid (CSF) Tau Protein in Alzheimer’s Disease and Vascular Dementia
BACKGROUND: Alzheimer’s disease (AD) has high a prevalence rate, high medical costs, and care difficulties, and has become a serious social and economic problem in our aging society. So far, there has not been a reliable and objective diagnostic criteria for AD found. In recent years, there have bee...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Shanghai Municipal Bureau of Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434283/ https://www.ncbi.nlm.nih.gov/pubmed/28638201 http://dx.doi.org/10.11919/j.issn.1002-0829.216068 |
Ejemplares similares
-
Tau oligomers in cerebrospinal fluid in Alzheimer's disease
por: Sengupta, Urmi, et al.
Publicado: (2017) -
Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer’s Disease
por: Geijselaers, Stefan L.C., et al.
Publicado: (2017) -
Cerebrospinal Fluid Total Tau Protein Correlates With Longitudinal, Progressing Cognitive Dysfunction in Anti-Neural Autoantibody-Associated Dementia and Alzheimer’s Dementia: A Case–Control Study
por: Hansen, Niels, et al.
Publicado: (2022) -
Tau protein as a possible marker of cerebrospinal fluid leakage in cerebrospinal fluid rhinorrhoea: A pilot study
por: Oudart, Jean-Baptiste, et al.
Publicado: (2017) -
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
por: Mattsson, Niklas, et al.
Publicado: (2016)